The Wall Street Journal: Pfizer Sets Up Succession Plan With Creation Of Operating Chief Role Pfizer Inc. named executive Albert Bourla to a newly created position of chief operating officer, putting him first in line to succeed Chief Executive Ian Read at the helm of one of the world's largest drug companies. In the new role, which takes effect Jan. 1, Dr. Bourla will oversee all sales, strategy, manufacturing and later-stage drug development at Pfizer. Drug research, financials, compliance and human resources will keep reporting to Mr. Read. (Rockoff, 11/13)